J Aschan

6.5k citations

107 papers · 4.8k indexed · 1 hit paper · h-index 39

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 1%

Papers in

Hematology 85
- Hematopoietic Stem Cell Transplantation 70
- Multiple Myeloma Research and Treatments 16
- Acute Myeloid Leukemia Research 15
Transplantation 4

Co-authors: Olle Ringdén Per Ljungman Mats Remberger Lisbeth Barkholt Jacek Winiarski Jonas Mattsson Mehmet Uzunel B Lönnqvist
Journals: Bone Marrow Transplantation (22 papers)Blood (10 papers)Transplantation (9 papers)Clinical Transplantation (5 papers)European Journal Of Haematology (5 papers)
Partner nations: Sweden United States Germany

In The Last Decade

J Aschan

105 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease 2006 · 893 citations

Peers

Countries citing papers authored by J Aschan

Since Specialization

Citations

This map shows the geographic impact of J Aschan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Aschan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Aschan more than expected).

Fields of papers citing papers by J Aschan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Aschan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Aschan. The network helps show where J Aschan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J Aschan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J Aschan Line = papers co-authored together J Aschan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT) Value in Health ·Bart Heeg, Michel van Agthoven, Шипилова Ольга Вадимовна, Johan Liwing, Marzieh Shokouhifar, Torben Plesner, Zan Xu, J Aschan, Hermann Einsele, M. Treur, Чжоу Цун, Paul G. Richardson, Antonio Palumbo, Hareth Nahi, Pieter Sonneveld	2014	2
2	Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma – a retrospective population based study of 1162 patients European Journal Of Haematology ·Johan Lund, Katarina Uttervall, Johan Liwing, Gösta Gahrton, Evren Alici, J Aschan, Erik Holmberg, Hareth Nahi	2013	4
3	Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation Bone Marrow Transplantation ·Andreas T. Björklund, J Aschan, Myriam Labopin, Mats Remberger, Olle Ringdén, Jacek Winiarski, Per Ljungman	2007	62
4	Myeloablative and immunosuppressive properties of treosulfan in mice Experimental Hematology ·Halehalli L. Anusha, Zuzana Hassan, Manuchehr Abedi‐Valugerdi, Laimonas Griškevičius, Christína Nilsson, Mats Remberger, J Aschan, Hérnan Concha, 張凌倫, Moustapha Hassan	2006	60
5	Cytolytic T Cell Reactivity to Epstein-Barr Virus Is Lost During In Vitro T Cell Expansion Journal of Hematotherapy & Stem Cell Research ·Stefan Carlens, Milagros del Carmen Quispe Villarreal, Olle Ringdén, J Aschan, Birger Christensson, Victor Levitsky, M. Siraç Dilber	2002	9
6	Mixed chimaerism is common at the time of acute graft‐versus‐host disease and disease response in patients receiving non‐myeloablative conditioning and allogeneic stem cell transplantation British Journal of Haematology ·Jonas Mattsson, Mehmet Uzunel, Mats Brune, P Hentschke, Lisbeth Barkholt, Ulrika Stierner, J Aschan, Olle Ringdén	2001	51
7	Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation Leukemia ·Jonas Mattsson, Mehmet Uzunel, 下田正二郎, J Aschan, Olle Ringdén	2001	100
8	Pharmacokinetics of liposomal busulphan in man Bone Marrow Transplantation ·Zeinab Hassan, Per Ljungman, Olle Ringdén, Jacek Winiarski, Christina Nilsson, J Aschan, Yanuar Fajarsunarimo, Moustapha Hassan	2001	22
9	The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse Biology of Blood and Marrow Transplantation ·Stefan Carlens, Mats Remberger, J Aschan, Olle Ringdén	2001	42
10	Treatment of severe acute graft‐versus‐host disease with anti‐thymocyte globulin Clinical Transplantation ·Mats Remberger, J Aschan, Lisbeth Barkholt, J Tollemar, Olle Ringdén	2001	62
11	A graft-versus-colonic cancer effect of allogeneic stem cell transplantation Bone Marrow Transplantation ·Henrik Zetterquist, P Hentschke, A. Thörne, Annika Wernerson, Jonas Mattsson, Mehmet Uzunel, Arindam Mitra, Nils Albiin, J Aschan, Nikos Papadogiannakis, Olle Ringdén	2001	30
12	Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients Bone Marrow Transplantation ·P Hentschke, Hans Hägglund, Jonas Mattsson, Stefan Carlens, B Lönnqvist, Per Ljungman, J Aschan, S. Fredrikson, Olle Ringdén	1999	10
13	Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation ·Mats Remberger, Olle Ringdén, Per Ljungman, H Hägglund, Jacek Winiarski, B Lönnqvist, J Aschan	1998	44
14	RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1 Transplantation ·E.J. Hughes-Davis, J Aschan, Ilona Lewensohn‐Fuchs, Stefan Carlens, Petr SKOK, P.N. Rao, Jonas Mattsson, E. Sparrelid, Jacek Winiarski, Olle Ringd n	1998	131
15	Transplantation with unrelated bone marrow in leukemic patients above 40 years of age Transplantation Proceedings ·Olle Ringdén, Mats Remberger, Jonas Mattsson, J Aschan, Hans Hägglund, Stefan Carlens, Andrea Savio, E. Sparrelid, Per Ljungman	1997	1
16	Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections Bone Marrow Transplantation ·E. Sparrelid, Per Ljungman, 幸美村田, J Aschan, Olle Ringdén, Jacek Winiarski, Björn E. Wahlin, Jan Andersson	1997	89
17	Graft-versus-myeloma effect [letter] The Lancet ·J Aschan	1996	8
18	Oral Ribavirin for Prevention of Severe Liver Disease Caused by Hepatitis C Virus During Allogeneic Bone Marrow Transplantation Clinical Infectious Diseases ·Per Ljungman, Jan Andersson, J Aschan, B. Björkstrand, H Hägglund, B Lönnqvist, Olle Ringdén, Jacek Winiarski	1996	21
19	Increased risk of relapse in patients with chronic myelogenous leukemia given T‐cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft‐versus‐host disease European Journal Of Haematology ·J Aschan, Olle Ringdén, Berit Sundberg, Sven Klaesson, Per Ljungman, B Lönnqvist	1993	21
20	Foscarnet for Treatment of Cytomegalovirus Infections in Bone Marrow Transplant Recipients Scandinavian Journal of Infectious Diseases ·J Aschan, Olle Ringdén, Per Ljungman, B Lönnqvist, S. Ohlman	1992	36

About J Aschan

J Aschan is a scholar working on Hematology, Transplantation, Oncology, Genetics and Immunology, having authored 107 papers that have together received 4.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (70 papers), Cytomegalovirus and herpesvirus research (20 papers), Multiple Myeloma Research and Treatments (16 papers), Acute Lymphoblastic Leukemia research (16 papers), Polyomavirus and related diseases (15 papers), Acute Myeloid Leukemia Research (15 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (10 papers). The work is most often cited by research in Hematology (2.7k citations), Transplantation (289 citations), Genetics (1.1k citations), Immunology (1.3k citations) and Oncology (1.1k citations). J Aschan has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Olle Ringdén, Per Ljungman, Mats Remberger, Lisbeth Barkholt, Jacek Winiarski, Jonas Mattsson, Mehmet Uzunel, B Lönnqvist, Berit Sundberg and Stefan Carlens. Their work appears in journals such as Bone Marrow Transplantation, Blood, Transplantation, Clinical Transplantation and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact